Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients

Fig. 2

The 10-year event-free survival (EFS) rates in the low risk (LR) and high risk (HR) groups were 88.6 ± 4.5 and 86.8 ± 5.2%, respectively (a). Events were defined as death, relapse, or secondary malignant neoplasms. The 10-year overall survival (OS) rates were 98.3 ± 1.7 and 91.8 ± 3.9% in the LR and HR groups, respectively (b)

Back to article page